These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 10080934

  • 1. Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.
    Graham LD, Whitelock JM, Underwood PA.
    Biochem Biophys Res Commun; 1999 Mar 24; 256(3):542-8. PubMed ID: 10080934
    [Abstract] [Full Text] [Related]

  • 2. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation.
    Sekiguchi RT, Potter-Perigo S, Braun K, Miller J, Ngo C, Fukuchi K, Wight TN, Kimata K, Snow AD.
    J Neurosci Res; 1994 Aug 15; 38(6):670-86. PubMed ID: 7807583
    [Abstract] [Full Text] [Related]

  • 3. Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells.
    Kokenyesi R, Silbert JE.
    Biochem Biophys Res Commun; 1995 Jun 06; 211(1):262-7. PubMed ID: 7779094
    [Abstract] [Full Text] [Related]

  • 4. Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan.
    Tapanadechopone P, Hassell JR, Rigatti B, Couchman JR.
    Biochem Biophys Res Commun; 1999 Nov 30; 265(3):680-90. PubMed ID: 10600481
    [Abstract] [Full Text] [Related]

  • 5. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
    Vischer P, Feitsma K, Schön P, Völker W.
    Eur J Cell Biol; 1997 Aug 30; 73(4):332-43. PubMed ID: 9270876
    [Abstract] [Full Text] [Related]

  • 6. Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells.
    Dodge GR, Boesler EW, Jimenez SA.
    Lab Invest; 1995 Nov 30; 73(5):649-57. PubMed ID: 7474938
    [Abstract] [Full Text] [Related]

  • 7. Isolation and characterization of proteoglycans from human follicular fluid.
    Eriksen GV, Carlstedt I, Mörgelin M, Uldbjerg N, Malmström A.
    Biochem J; 1999 Jun 15; 340 ( Pt 3)(Pt 3):613-20. PubMed ID: 10359644
    [Abstract] [Full Text] [Related]

  • 8. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V.
    Friedrich MV, Göhring W, Mörgelin M, Brancaccio A, David G, Timpl R.
    J Mol Biol; 1999 Nov 19; 294(1):259-70. PubMed ID: 10556044
    [Abstract] [Full Text] [Related]

  • 9. Analysis of glycosaminoglycan chains from different proteoglycan populations in human embryonic skin fibroblasts.
    Schmidtchen A, Fransson LA.
    Eur J Biochem; 1992 Sep 01; 208(2):537-46. PubMed ID: 1521543
    [Abstract] [Full Text] [Related]

  • 10. Differentially expressed patterns of glycosaminoglycan structure in heparan sulfate proteoglycans and free chains.
    Hovingh P, Piepkorn M, Linker A.
    Eur J Biochem; 1993 Feb 01; 211(3):771-9. PubMed ID: 8436134
    [Abstract] [Full Text] [Related]

  • 11. Analysis of proteoglycan expression in developing chicken brain: characterization of a heparan sulfate proteoglycan that interacts with the neural cell adhesion molecule.
    Burg MA, Halfter W, Cole GJ.
    J Neurosci Res; 1995 May 01; 41(1):49-64. PubMed ID: 7674377
    [Abstract] [Full Text] [Related]

  • 12. Alterations of heparan sulfate moieties in cultured endothelial cells exposed to endotoxin.
    Colburn P, Dietrich CP, Buonassisi V.
    Arch Biochem Biophys; 1996 Jan 01; 325(1):129-38. PubMed ID: 8554337
    [Abstract] [Full Text] [Related]

  • 13. Lead inhibits the core protein synthesis of a large heparan sulfate proteoglycan perlecan by proliferating vascular endothelial cells in culture.
    Fujiwara Y, Kaji T.
    Toxicology; 1999 Apr 15; 133(2-3):159-69. PubMed ID: 10378482
    [Abstract] [Full Text] [Related]

  • 14. Expression and characterization of minican, a recombinant syndecan-1 with extensively truncated core protein.
    Viklund L, Loo BM, Hermonen J, El-Darwish K, Jalkanen M, Salmivirta M.
    Biochem Biophys Res Commun; 2002 Jan 11; 290(1):146-52. PubMed ID: 11779146
    [Abstract] [Full Text] [Related]

  • 15. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
    Kosir MA, Quinn CC, Wang W, Tromp G.
    J Surg Res; 2000 Jul 11; 92(1):45-52. PubMed ID: 10864481
    [Abstract] [Full Text] [Related]

  • 16. Isolation and partial characterization of a cell-surface heparan sulfate proteoglycan from embryonic rat spinal cord.
    Giuseppetti JM, McCarthy JB, Letourneau PC.
    J Neurosci Res; 1994 Apr 01; 37(5):584-95. PubMed ID: 8028039
    [Abstract] [Full Text] [Related]

  • 17. The malaria circumsporozoite protein: interaction of the conserved regions I and II-plus with heparin-like oligosaccharides in heparan sulfate.
    Ying P, Shakibaei M, Patankar MS, Clavijo P, Beavis RC, Clark GF, Frevert U.
    Exp Parasitol; 1997 Feb 01; 85(2):168-82. PubMed ID: 9030667
    [Abstract] [Full Text] [Related]

  • 18. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
    Engbring JA, Hoffman MP, Karmand AJ, Kleinman HK.
    Cancer Res; 2002 Jun 15; 62(12):3549-54. PubMed ID: 12068003
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.